Tag archive for ‘Pharmaceuticals’
News Brief On Thursday, November 19th, 2015

Pfizer’s talks to acquire Allergan in a $150 billion deal

Pfizer’s talks to acquire Allergan in a $150 billion deal that would see the US drug giant redomicile in Ireland accelerated on Wednesday, as the US Treasury prepared to clamp down further on such tax More...

Hillel Koren On Tuesday, April 21st, 2015

Teva bid for Mylan could come today – Bloomberg

Bloomberg reports that Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) could publish a bid for its US rival Mylan Inc. (MYL) today, in what could turn out to be the largest deal of the year in More...

Gil Tanenbaum On Sunday, January 18th, 2015

Israel Gives Oramed New Patent for Oral Administrations of Exenatide

The Israel Patent Office has granted Israel’s Oramed Pharmaceuticals, a developer of oral drug delivery systems, a patent for its invention, titled “Methods and Compositions for Oral Administrations More...

Teva launches generic blood pressure treatment in US

– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in More...

Eli Horn On Monday, December 29th, 2014

Biotech Company Juno Therapeutics Possibly on George Soros’ Radar

Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company The Motley Fool said. As of the end More...

Tzvi Ben-Gedalyahu On Tuesday, December 16th, 2014

Israeli Marijuana Companies Smoking Up Wall Street

Originally published by The Jewish Press. The Israeli-bases One World Cannabis (OWC) company is going to be traded over the counter on Wall Street after the Dynamic Applications merges with it, Globes business More...

Vered Weiss On Monday, December 15th, 2014

George Soros Dumps Biotech

–   The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about a bubble, as reported by Motley Fool.     The iShares  More...

Reuters On Tuesday, December 9th, 2014

Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making More...

Gil Tanenbaum On Thursday, November 20th, 2014

Israel’s Immune Pharmaceuticals to Issue New Stock

Israel’s Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases More...

Reuters On Tuesday, November 18th, 2014

Ackman supports Allergan’s $66 billion sale to Actavis

– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...

Wordpress site Developed by Fixing WordPress Problems